The mouse cell lines tested in this study that score 98% allele agreement or higher between the Consortium laboratory members are now available on the NCBI BioSample Database under BioProject accession \# PRJNA539973, at the following URL: <https://www.ncbi.nlm.nih.gov/biosample/?term=mouse+cell+line+STR+profile%5Battribute+name%5D>.

Introduction {#sec001}
============

The impact of misidentification and cross-contamination of animal cell lines in the scientific community continues to be a serious problem \[[@pone.0218412.ref001], [@pone.0218412.ref002]\]. Although some journals require cell line authentication prior to publication \[[@pone.0218412.ref002]\], others only recommend it, allowing for non-validated materials and possible misinformation to enter the public domain. The scientific community and funding agencies are encouraging data transparency to improve reproducibility and the quality of research (<https://grants.nih.gov/reproducibility/index.htm>) \[[@pone.0218412.ref003]--[@pone.0218412.ref006]\]. One aspect of reproducibility is validating the biological reagents used in experiments to include cell lines which continue to be the main work horse in biological research. For human cell lines there are validated methods \[[@pone.0218412.ref007]\], kits, and databases available for intraspecies identity testing. For non-human cell lines there are validated methods for interspecies identification such as DNA barcoding \[[@pone.0218412.ref008]\] and the species-specific multiplex PCR assay \[[@pone.0218412.ref009]\] (ASN-0004: Species-Level Identification and Cross-Contamination Screening in Animal Cells by Multiplex PCR--Working group in progress); however, these methods are unable to distinguish between non-human cell lines of the same species.

Mouse models have been an important tool in biomedical research, especially with the advancement of transgenic mouse technologies, such as the CRISPR/Cas9 system \[[@pone.0218412.ref010]\]. With the increasing number of transgenic systems and potential new cell lines created, there is a need for intraspecies identification of mouse cell lines. Indeed, mouse cell lines are the second most frequently used cell lines in basic research when compared to human cell lines. The Mouse Cell Line Authentication Consortium was formed to validate a short tandem repeat (STR) multiplex PCR assay to distinguish among mouse cell lines. This assay improves upon the patented methods (US Patent 9,556,482 B2) previously described \[[@pone.0218412.ref011]\], which now includes additional primers that target a total of 19 mouse STR loci and two human STR markers for contamination detection (US patent application publication 2017/0101677 A1). This method is rapid, inexpensive, and uses related methods and instrumentation already in place for human cell line authentication by STR profiling. This validated method is the first step in authenticating a mouse cell line by determining its STR profile identity.

In October of 2016, a Federal Register Notice (FRN) was published inviting eligible laboratories to join the Mouse Cell Line Authentication Consortium (<https://www.federalregister.gov>; 81 FR 70665). Eleven laboratories responded to the FRN and formally signed a Cooperative Research and Development Agreement (CRADA) with NIST, the 12^th^ laboratory, to join the Consortium (see [Table 1](#pone.0218412.t001){ref-type="table"}). Test kits were distributed to Consortium laboratory members; each kit contained DNA isolated from 50 mouse cell lines (coded samples), primers, PCR Master Mix, calibrants, and control human DNA. Each Consortium laboratory member was provided a detailed protocol and asked to perform the assay as written. The protocol described how to amplify the STR target regions of the mouse DNA from the 50 cell lines using PCR, separate the amplicons using capillary electrophoresis (CE), size the fragments based on calibrants, and submit the exported data file to NIST. NIST analyzed the data and submitted comments to the Consortium members. Consortium members met on several occasions via webinar and teleconference calls to discuss the interpretation and analysis of the submitted data.

10.1371/journal.pone.0218412.t001

###### Consortium laboratory members.

![](pone.0218412.t001){#pone.0218412.t001g}

  Affiliation                  Institution   Country
  ---------------------------- ------------- -------------
  ATCC                         Cell Bank     USA
  Charles River Laboratories   Industry      USA
  Duke University              Academia      USA
  Francis Crick Institute      Academia      UK
  Genetica Cell Line Testing   Industry      USA
  IDEXX BioAnalytics           Industry      USA
  Laragen Inc.                 Industry      USA
  Microsynth AG                Industry      Switzerland
  NIST                         Government    USA
  University of Arizona        Academia      USA
  University of Cambridge      Academia      UK
  University of Pittsburgh     Academia      USA

This multiplex PCR assay provides a unique STR profile for each mouse cell line tested, including closely related cell lines. Moreover, cell lines from within a mouse strain showed conserved alleles at particular loci that can be used to identify cell lines at the strain level, enabling the detection of misidentified cell lines. Here we describe the results of the study in detail and the path forward.

Results {#sec002}
=======

Initial data analysis {#sec003}
---------------------

Upon observation of the first set of data submitted to NIST, it was apparent that interpretation of data was inconsistent among the Consortium laboratory members primarily due to PCR artifacts, and to a lesser extent, low signal and genotyping (bin) errors. PCR artifacts, mainly stutter, were a major factor in the discordant allele calls. The electropherograms for each cell line were very similar among Consortium laboratory members, but interpretation of allele calls, most notably peaks in the +4 and -4 stutter positions, varied. Stutter is a PCR artifact that is caused by strand slippage of the polymerase enzyme during amplification resulting in a small peak that occurs either one repeat before or after the true allele at a STR marker \[[@pone.0218412.ref012], [@pone.0218412.ref013]\]. The STR loci targeted in this assay are tetranucleotide repeats; therefore, the stutter appears either four base pairs before or after the true allele. Traditionally, stutter filters are used in fragment analysis software to flag a peak in the stutter position as being a potential allele or an artifact. Since stutter filters were not yet established for the mouse cell line STR profiling assay, some Consortium laboratory members relied on default stutter filters validated for human cell lines in their software to call alleles for each sample. Consequently, some alleles were missed due to the lack of pre-established stutter filters.

Data analysis using stutter rules {#sec004}
---------------------------------

Since stutter filters for the mouse cell line STR profiling assay were not yet established, the Consortium laboratory members in a consensus pronouncement, determined the stutter filter settings based on the data. The stutter ratios were calculated based on the following rules: (1) any peak in the -4 stutter position with a stutter ratio greater than 20% would be called an allele, and (2) any peak in the +4 stutter position with a stutter ratio above 10% would be called an allele. The Consortium laboratory members were also asked to ensure that each allele was properly labeled since the exported data file only included information for peaks that were assigned an allele call. Using these guidelines, the Consortium achieved full concordance in 18 out of 50 mouse cell lines (see Concordance section). A large part of discordance was due to variations in data interpretation, specifically the lack of stutter ratio calculations, and in some cases low instrument signal. Consortium laboratory members were asked to provide reasons for discordance including errors in stutter ratio calculations, artifacts present, or low signal. These determinations led to corrections in final allele calls. After establishing rules and offering several training webinars, the consensus allele calls among the Consortium laboratory members improved to over 92% (see Concordance section under Results).

Stutter ratio comparison across laboratories {#sec005}
--------------------------------------------

To determine if stutter ratios vary across the different instrument platforms in the interlaboratory study, stutter ratios were analyzed in DNA samples from normal mouse tissue (diploid) for each represented allele in the calibrant samples (C1 though C5, see [Materials and methods](#sec015){ref-type="sec"}) from all Consortium laboratory members. As seen in literature, stutter ratios increased with increasing number of uninterrupted repeats (see [Fig 1](#pone.0218412.g001){ref-type="fig"}), except in some microvariant alleles where the longest uninterrupted repeat is shorter than what was found in the full repeat \[[@pone.0218412.ref014]\].

![Stutter ratios calculated from diploid mouse DNA samples.\
Each marker with associated stutter ratios for the represented alleles is plotted here. The y-axis is the observed percent stutter ratio and x-axis shows the allele number (number of repeats).](pone.0218412.g001){#pone.0218412.g001}

The stutter ratios across alleles were then normalized for repeat length, since this was the most prominent source of variation. That is, each observed stutter ratio was divided by the average of all stutter ratios observed for the same marker and allele combination (see [Fig 2](#pone.0218412.g002){ref-type="fig"}).

![Normalizing stutter across alleles.\
The y-axis shows each observed stutter ratio divided by the average of all stutter ratios observed for the same marker and allele. The x-axis shows the allele number (number of repeats).](pone.0218412.g002){#pone.0218412.g002}

To see a trend or pattern across the relationships of the instruments, the average normalized stutter ratio was computed for each instrument within each marker. The Friedman test \[[@pone.0218412.ref015]\], an analysis looking for trends among ranks, was applied and showed that there was a statistically significant difference between the instruments (see [Fig 3](#pone.0218412.g003){ref-type="fig"}). Stutter ratios from either the ABI 3130xl or 3500xl instruments were found to be roughly 1% lower on average than stutter ratios from either the ABI 3730 and 3730xl instruments. Although statistically significant, the difference is negligible from a practical perspective, as it is roughly the same size as variability in stutter ratios observed from one CE run to another on different days using the same instrument and running the same sample.

![Summary of the effect of instrument on stutter ratio across markers.\
The combination across the 19 STR markers and relative position for each of the instruments is condensed into a single plot. Each line corresponds to a particular marker, where the four points on each line denote the respective average normalized stutter ratios within that STR marker for the four instruments.](pone.0218412.g003){#pone.0218412.g003}

Stutter filter recommendations determined from this study {#sec006}
---------------------------------------------------------

Stutter filters for the mouse multiplex PCR assay were not available during the interlaboratory study. However, data from the study were used to create stutter filter recommendations for future studies. The stutter ratios calculated are allele-specific (see [S1 Table](#pone.0218412.s005){ref-type="supplementary-material"}). Currently, most available software only allows the addition of marker-specific stutter filters. For this study, marker-specific stutter was calculated across represented alleles from normal, diploid mouse DNA by taking the mean of the stutter ratios for all alleles at a specific locus and three standard deviations were added (see [Table 2](#pone.0218412.t002){ref-type="table"}). This method has been used previously for marker-specific stutter filters for human STRs \[[@pone.0218412.ref016]\]. As seen in [Table 2](#pone.0218412.t002){ref-type="table"}, there are two loci (18--3 and 13--1) that have stutter filter recommendations above the 20% stutter threshold that was used to make allele calls in this study. Only DNA from normal, diploid samples was used in calculating stutter ratios. Therefore, some alleles that are present in cancer cell lines may not be represented in the marker-specific stutter recommendations. Application of this recommendation led to consistent allele calls.

10.1371/journal.pone.0218412.t002

###### Marker-specific stutter filter recommendations.
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  STR Marker   Known Allele Range   Stutter Ratio (%)   Allele Range Represented in Stutter Ratio Calculation
  ------------ -------------------- ------------------- -------------------------------------------------------
  18--3        13--28               20.52               16--23
  4--2         13--23.3             13.80               16.3--22.3
  11--1        17--23.3             19.75               17.3--23.3
  6--7         11--26               16.13               12--26
  19--2        10--16               11.77               10--16
  1--2         12--30.1             13.20               13--22
  7--1         19.2--33.2           12.98               24.2--33.2
  1--1         10--19               13.71               10--20
  3--2         9--25                16.07               9--25
  8--1         6--19                18.12               6--18.3
  2--1         8--17.1              17.71               9--16
  15--3        12--31.3             19.03               18.3--27.3
  6--4         12.2--21             12.16               15.3--21
  11--2        12--26.2             17.16               15--26.2
  17--2        11--22               16.98               12--22
  12--1        15--24.1             11.90               15--23
  5--5         11--22               13.72               11--21
  X-1          15.2--37             18.74               21--37
  13--1        11--20.1             22.60               11--20.1

The allele-specific stutter filter would be useful in determining allele calls for these markers, especially at the lower repeat number (allele) that have a much smaller associated percent stutter. In the future, stutter filters will be incorporated into the data analysis software program and will be used to flag alleles that need to be examined more closely. If the sample is composed of a mixture of cell lines, then stutter filters cannot be applied to the data set, since multiple contributors may have varying peak heights in the profile that can invalidate the stutter filters. It is important to note that not all alleles were represented in the stutter filter calculations.

Signal intensity {#sec007}
----------------

Signal intensity was appropriate to allow for genotyping of the cell lines. The signals were above threshold limits and accurate allele calls were made for a nominal starting amount of 2 ng of DNA. Accurate quantitation to determine DNA concentration is important for optimal signal intensity (see [Methods](#sec015){ref-type="sec"} section). In few cases, low signal was observed in the red dye channel, the lowest fluorescence intensity of all the dyes, for markers X-1 and 13--1. This may be due to a lower DNA amount resulting from loss of DNA to the walls of the tube or pipetting error. The low signal can be remedied by increasing the amount of DNA in the PCR reaction mix, changing the injection time/voltage during CE, or increasing the number of cycles during PCR.

Genotyping (Bin) {#sec008}
----------------

Genotyping is the determination of allele calls among STR markers. In order to make accurate allele calls or genotyping, bins were created. Bins are place holders in the software for converting imprecise DNA fragments into alleles that have been determined based on sequenced calibrants (refer to [S2](#pone.0218412.s002){ref-type="supplementary-material"} and [S3](#pone.0218412.s003){ref-type="supplementary-material"} Files for protocol information regarding establishing bins in the different software platforms). Calibrants, which are sequenced diploid DNA extracts from known mouse strains, were used to adjust bins, optimize the assay on the different instrument platforms (see [Table 3](#pone.0218412.t003){ref-type="table"}), and to aid in accurate allele calling (reference [S2](#pone.0218412.s002){ref-type="supplementary-material"} and [S3](#pone.0218412.s003){ref-type="supplementary-material"} Files). Optimized protocols for capillary electrophoresis were determined by each Consortium laboratory member and the parameters are described in [Table 4](#pone.0218412.t004){ref-type="table"}.

10.1371/journal.pone.0218412.t003

###### Consortium laboratory member instrument, polymer, array, and software used in the interlaboratory study.
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  Group   Instrument   Array   Polymer   Software
  ------- ------------ ------- --------- --------------------------
  1       ABI 3130xl   36 cm   POP-4     GeneMapper v5.0
  2       ABI 3130xl   50 cm   POP-7     GeneMapper v5.0
  3       ABI 3130xl   36 cm   POP-4     GeneMapper ID v3.2.1
  4       ABI 3130xl   50 cm   POP-7     GeneMapper v5.0
  5       ABI 3730xl   50 cm   POP-7     GeneMapper 4.0
  6       ABI 3130xl   36 cm   POP-4     GeneMapper v4.0
  7       ABI 3730xl   50 cm   POP-7     GeneMapper v4.0, v5.0
  8       ABI 3730xl   50 cm   POP-7     Gene Marker v2.7.6
  9       ABI 3130xl   36 cm   POP-4     GeneMapper v4.1, v5.0
  10      ABI 3730     36 cm   POP-7     GeneMarker v1.85, v2.6.3
  11      ABI 3500xl   50 cm   POP-7     GeneMapper ID-X v1.2
  12      ABI 3500xl   36 cm   POP-4     GeneMapper ID-X v1.3

10.1371/journal.pone.0218412.t004

###### Parameters for capillary electrophoresis for each group.
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  Group          CE Parameters
  -------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **1, 9, 12**   **ABI 3500xl, ABI3130xl, 36cm array using POP-4**: oven temp (60 °C), run time (1500 sec), run voltage (15 kV), pre-run time (180 sec), pre-run voltage (15 kV), injection time (15 sec), injection voltage (1.2 kV), and data delay (1 sec).
  **11**         **ABI 3500xl 50cm array with POP-7**: oven temp (60 °C), run time (2000 sec), run voltage (15 kV), pre-run time (180 sec), pre-run voltage (15 kV), injection time (15 sec), injection voltage (1.2 kV), and data delay (1 sec).
  **2**          **ABI 3130xl 50cm array with POP-7**: oven temp (60 °C), run time (6000 sec), run voltage (15kV), pre-run time (180 sec), pre-run voltage (15 kV), injection time (15 sec), injection voltage (1.6 kV), and data delay (200 sec).
  **4**          **ABI 3130xl 50cm array with POP-4**: oven temp (60 °C), run time (2200 sec), run voltage (15 kV), pre-run time (180 sec), pre-run voltage (15 kV), injection time (15 sec), injection voltage (1.6 kV), and data delay (500 sec).
  **3, 6**       **ABI 3130xl 36cm array with POP-4**: oven temp (60 °C), run time (1500--2700 sec), run voltage (15 kV), pre-run time (180 sec), pre-run voltage (15 kV), injection time (10 sec), injection voltage (3 kV), and data delay (1 sec).
  **7**          **ABI 3730xl 50cm array with POP-7**: oven temp (63 °C), run time (5000 sec), run voltage (10 kV), pre-run time (180 sec), pre-run voltage (15 kV), injection time (25 sec), injection voltage (1.6 kV), and data delay (NA).
  **8**          **ABI 3730xl 50cm array with POP-7**: oven temp (63 °C), run time (2100 sec), run voltage (15 kV), pre-run time (180 sec), pre-run voltage (15 kV), injection time (10 sec), injection voltage (1.6 kV), and data delay (500 sec).
  **5**          **ABI 3730xl 50cm array with POP-7**: oven temp (60 °C), run time (3000 sec), run voltage (15 kV), pre-run time (180 sec), pre-run voltage (15 kV), injection time (15 sec), injection voltage (1.2 kV), and data delay (1 sec).
  **10**         **ABI 3730 36cm array with POP-7**: oven temp (66 °C), run time (1200 sec), run voltage (15 kV), pre-run time (180 sec), pre-run voltage (15 kV), injection time (10 sec), injection voltage (2 kV), and data delay (120 sec).

The calibrants covered 111 alleles (67%) of the 165 alleles observed in the 50 mouse cell lines. There was sufficient allele coverage by the calibrants for accurate allele calls of 49 of the 50 cell lines tested; consequently, identifying alleles in the test samples using extrapolation of alleles in the calibrants was successful. However, there was one exception for cell line C1498, when extrapolation of calibrants was unsuccessful for STR marker 18--3. Allele 28, at STR marker 18--3, fell outside the range of the calibrant at allele 22. Sanger sequencing at marker 18--3 confirmed the allele had 28 repeats. Increased coverage of alleles would improve allele calls with the application of an allelic ladder. These calibrants used for genotyping are not a renewable source. NIST and ATCC are currently developing an allelic ladder for the mouse STR markers.

Human cell line control sample {#sec009}
------------------------------

The human diploid palatal mesenchymal cell line, HEPM, was used as a control to detect contamination of human cells by confirming the presence of primers for two human STR markers, D8S1106 and D4S2408. The STR markers were incorporated in the multiplex PCR assay to test for human contamination of mouse cell lines. The electropherogram for the human control DNA obtained from HEPM is shown in [S1 Fig](#pone.0218412.s012){ref-type="supplementary-material"}. All human control samples resulted in amplified products exclusively sized in the human STR regions. In this study, no human cell line contamination was observed in the fifty mouse cell lines tested. Previous studies described sensitivity of the human STR markers \[[@pone.0218412.ref011]\] in an assay targeting nine mouse STR loci with levels of human contamination detected as low as 62 pg of DNA. Similar results were found when DNA from HEPM cells were tested with the additional mouse STR markers used in this interlaboratory study.

Removal of STR marker 11--1 {#sec010}
---------------------------

STR marker 11--1 was one of the original 19 markers analyzed by the Consortium and was ultimately removed. The removal of this marker did not change the informativeness of the remaining 18 STR markers to discriminate among the 50 mouse cell lines (see [S2 Table](#pone.0218412.s006){ref-type="supplementary-material"}). The marker for 11--1 was removed due to an abnormal peak morphology which appears as a "shoulder" either +1 or -1 bp from the true allele (see [Fig 4](#pone.0218412.g004){ref-type="fig"}), leading to discordant results. This phenomenon, most likely incomplete adenylation, was seen in STR genotyping from both diploid DNA samples and cell lines, and could not be resolved with a modification of the PCR that included an increased 4 h soak time at 60 °C at the end of the thermal cycling program or with added Pigtail sequences to the 5' end of the reverse primer \[[@pone.0218412.ref017]\]. The "shoulder" appears most prominently in full repeat alleles, such as allele 19, and is less of a problem for microvariants, such as allele 20.3 ([Fig 4](#pone.0218412.g004){ref-type="fig"}).

![Peak morphology of STR marker 11--1.\
A. Arrow denotes irregular peak morphology of allele 19 from diploid DNA from an AKR mouse (Jackson Laboratories). B. Arrow denotes irregular peak morphology of allele 19 from the JC cancer cell line. C. Normal peak morphology of allele 20.3 from diploid DNA from C58 mouse (Jackson Laboratories). D. Normal peak morphology of allele 20.3 from the CMT-93 cancer cell line. E. Arrows denote irregular peak morphology of allele 19 from the CT26.CL25 cancer cell line.](pone.0218412.g004){#pone.0218412.g004}

Concordant results {#sec011}
------------------

Review of the raw data (electropherogram) for each Consortium laboratory member showed concordance for the 50 cell lines. However, using 19 STR markers data misinterpretation resulted in discordance for 32 of the 50 cell lines. The reasons for discordance include high or low DNA amount, stutter calculation errors, missed allele, bin error, and artifacts. All of these interpretation errors can be resolved with training and experience. A sample was labeled discordant if one or more alleles was miscalled, for example, the NIH/3T3 cell line resulted in 311 out of 312 correct allele calls (99.6% consensus allele calls among the Consortium laboratory members) (see [Table 5](#pone.0218412.t005){ref-type="table"}). In this example, one allele (20.3) was missed at STR marker 4--2, resulting in a discordant cell line.

10.1371/journal.pone.0218412.t005

###### Discordant NIH/3T3 cell line.
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       STR Markers                                                                                                                
  ---- ------------- ------------ ---- ------- ------- ---- ---- ------- ---- --- ------ ------ ------- ------- ---- ------- ---- ------
  1    17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  2    17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  3    17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  4    17,19         19.3         12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  5    17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  6    17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  7    17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  8    17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  9    17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  10   17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  11   17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2
  12   17,19         19.3, 20.3   12   11,12   13,17   29   10   14,15   15   9   20.3   15.3   15,17   13,14   20   14,15   25   16.2

With the removal of STR marker 11--1, the Consortium laboratory members had concordant STR profiles for 21 of the 50 cell lines tested (see [Table 6](#pone.0218412.t006){ref-type="table"}). Allele calls for these 21 cell lines were in full concordance among the Consortium laboratory members at 18 STR loci.

10.1371/journal.pone.0218412.t006

###### Concordant STR profiles for 21 mouse cell lines.
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          Cell Lines                                                                                                                                                                                                          
  ------- ---------------- ------- ----------- ---------- ------ ------------ --------- ----------- ----------- ------ ----------- ----------- ----------- ------- ----------- ----------- ------- ------- ----------- ------ -------
  18--3   16               18      16,17       16         19     18           16,17     17          16,17       17     18,19       17,18       18          16      18,19       18          18      18,19   18          18     18
  4--2    20.3             21.3    20.3        20.3       20.3   20.3         13,21.3   19.3,20.3   18.3,19.3   20.3   21.3        21.3,22.3   22.3,23.3   19.3    21.3        21.3        20.3    21.3    21.3        21.3   22.3
  6--7    12               12      12          15         12     15           12        12          15          12     12          12          12          12      12          12          16      12      12          12     12
  19--2   12               14      12          14         12     12           12,14     11,12       10,11       13     14          13          12,14       12      13          12,13       13,14   12,13   14          14     14
  1--2    17               17      16          19,20      16     17           16,17     17          13          19     17,18       17          17          16      17,18       17,18       13      17      17          17     17
  7--1    25,26,27         25.2    27,28       26.2       25.2   25.2         26        28,29       25.2        26.2   24.2        25.2        25.2        26      25.2        25.2        25.2    26.2    24.2        25.2   25.2
  1--1    10               16      15,17       15         12     15, 16       10        10,16       14,15       17     14          15          15,16       10      15          11          16      14      15          16     15,16
  3--2    13,14            14      13          14         14     14           14        13,14       10          14     14          14          14          14      14          14          12      14      14          14     14
  8--1    16               13      16          16         16     16           16        15,16       15          16     13          13          13          16,17   13          16          16,17   13      13          13     13
  2--1    9                16      15          16         9      15, 16       9         9,16        14          9,16   16          16,17       16          9       16          16          9       15      16          16     16
  15--3   24.3,25.3,26.3   22.3    21.3,22.3   22.3       20.3   21.3, 22.3   26.3      20.3,21.3   17,18,19    22.3   22.3,23.3   22.3        22.3        25.3    22.3,23.3   22.3        22.3    22.3    23.3.24.3   22.3   22.3
  6--4    17,18            18      17          18,19      15.3   17,18        18        15.3,18     18,19       15     18          18,19       18          19      18          18          16.3    18      17          18     18
  11--2   15,16            17      17          16         15     15           16        17,19       16          16     17          17,18       17          17      18          15          15,16   18      16,17       17     17
  17--2   15               15,16   16          15,16      13     16,17        15        13,15       14          15     16          16          14,16       16      16          16          12      15      17          16     14,16
  12--1   16               16      16          17         19     16           16        16,20       17,18       17     16          16          16,17       16      16          16          16,17   16      16          16     16
  5--5    14               14      13          14,16,17   14     15           14        14,15       17,18       17     14          13,14       14          15      13,15       16          14      13,14   14          14     14
  X-1     26,27            25      27          27         26     27,28        26        25,27       25          28     25          26          25          27      24          26          26      24,25   26          25     24
  13--1   17               16.2    17          17         16.2   16.2,17      17        13,15.2     17.1        17     16.2        15.2        16.2        17      16.2        16.2,17.2   16.2    16.2    16.2        16.2   16.2

Although the remaining 29 cell lines were discordant, the percent of accurately calling alleles among the Consortium laboratory members were above 92% for all cell lines. Each discordant cell line is summarized with an average percent allele agreement, the corresponding number of STR markers that were discordant, and the reasons for discordance ([Table 7](#pone.0218412.t007){ref-type="table"}).

10.1371/journal.pone.0218412.t007

###### Summary of discordant cell line.
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                     At 18 Mouse STR Markers        
  ------------------ ------------------------- ---- ------------
  A9                 0.989                     2    b
  3T3-Swiss Albino   0.981                     2    a, d
  P3X63Ag8.653       0.994                     2    b
  Sp2/0-Ag14         0.984                     4    b, c, e
  LL/2 (LLC1)        0.991                     4    a, b, d, e
  NIH/3T3            0.997                     1    b
  McCoy B            0.981                     3    a, b, d
  WEHI 164           0.991                     1    c
  Hepa 1--6          0.986                     2    a, b, e
  HT-2 clone A5E     0.953                     7    a, b, c
  MLTC-1             0.993                     1    b
  E.G7-OVA           0.963                     5    b
  mIMCD-3            0.985                     2    d
  MS1                0.993                     1    b
  4T1                0.993                     2    b
  W-20-17            0.997                     1    e
  CT26.WT            0.977                     4    b
  CT26.CL25          0.990                     2    b
  Renca              0.997                     1    b
  B16-F0             0.990                     2    b
  B16-F1             0.995                     2    b
  A20                0.992                     1    b
  CTLL-2             0.991                     1    a
  D10.G4.1           0.982                     3    b, e
  EL4                0.963                     5    a, b, d
  C1498              0.967                     4    b, c
  P815               0.989                     2    a, b, c
  Sarcoma 180        0.918                     16   a, b, c
  WEHI-3             0.985                     5    b, c, e

\*Reasons for discordance are coded as follows: a. low fluorescent signal, b. error in calculation of stutter ratio, c. stutter ratio was at the stutter threshold, d. missed allele (not labeled), e. artifact (pull-up, dye blob, spike)

Cell lines that require further characterization {#sec012}
------------------------------------------------

Eight cell lines, HT-2 clone A5E, Sarcoma 180, McCoy B, BALB/3T3 clone A31, J558, E.G7-OVA, EL4, and C1498 were removed for misidentification, cross-contamination, or lack of consensus of allele calls among Consortium laboratory members. These eight cell lines will not be included in the NCBI BioSample database entry. A spleen cell line, HT-2 clone A5E, reported in the literature as being derived from a BALB/c mouse strain \[[@pone.0218412.ref018]\] exhibited greater similarity with a C57BL strain by sharing over 50% alleles. This cell line also has three alleles or more at seven loci, high peak height imbalance, and is discordant at eight STR markers. The HT-2 clone A5E cell line needs more characterization to determine if it is contaminated or misidentified due to the inconsistencies with the strain of origin and the increase of alleles per marker. Sarcoma 180 is another cell line that has high peak height imbalance and greater than three alleles at 17 loci, making it difficult to apply stutter filter guidelines. Additionally, two cell lines J558 and BALB/3T3 clone A31, purported to be unrelated, have 95% allele matching based on pairwise comparison using Master's algorithm (see [S3 Table](#pone.0218412.s007){ref-type="supplementary-material"}). These three cell lines requires further characterization to determine authenticity. There is limited information in the literature regarding a clear origin for the McCoy B cell line, which was initially described as originating from the parental cell line McCoy A, derived from synovial fluid in the knee from a human patient \[[@pone.0218412.ref019]\]. McCoy B cell line is of mouse origin, not human, and is a clear indication of misidentification \[[@pone.0218412.ref020]\]. The additional cell lines, E.G7-OVA, EL4, and C1498 have less than 97% consensus agreement in allele calls (see [Table 7](#pone.0218412.t007){ref-type="table"}), to include discordant calls at greater than four loci, and greater than three alleles present at a specific locus. These disagreements call for further characterization of these cell lines.

Pairwise comparison {#sec013}
-------------------

A pairwise comparison using Master's algorithm (percent match = number shared alleles/total number of alleles in the questioned profile) \[[@pone.0218412.ref021]\] was calculated on the mouse cell lines and control diploid mouse strains from commercial sources (Jackson Laboratories and Zyagen, Inc.) (see [S3 Table](#pone.0218412.s007){ref-type="supplementary-material"}). When a cell line was compared against itself it showed 100% matching. However, cell lines compared to its derivatives demonstrated a percent matching greater than 85% (see [Table 8](#pone.0218412.t008){ref-type="table"}). Moreover, cell lines derived from the same mouse strain, in some cases, showed high levels of relatedness (over 80%). Based on the matching algorithm data, there are several cell lines that need further studies due to high level of relatedness.

10.1371/journal.pone.0218412.t008

###### Percent matching of known related cell lines using Master's algorithm.
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  Parental Cell Line   Derivative of parental cell line   Percent Matching
  -------------------- ---------------------------------- ------------------
  NCTC clone 929       A9                                 85%
  WEHI 164             WEHI-13VAR                         91%
  CT26.WT              CT26.CL25                          87%
  B16-F0               B16-F1                             94%
  RAW 264.7            RAW 264.7 gamma NO-                95%

Discussion {#sec014}
==========

The mouse multiplex PCR assay for intraspecies mouse cell line identity testing was validated by the Mouse Cell Line Authentication Consortium. Overall, each Consortium laboratory member, using various instrumentation, polymers and arrays, generated STR profiles for the 50 mouse cell lines. Review of the electropherograms from the Consortium laboratory members showed concordance for the 50 cell lines. Cell lines that were known to be related showed greater than 85% matching alleles using Master's algorithm. Several reported related and unrelated cell lines showed greater than 80% allele matching and require further investigation. Data misinterpretation resulted in discordance based on 18 of the 19 STR markers. All of these discordant allele calls can be resolved with training and experience.

The Consortium started out with 19 STR markers to validate mouse cell lines and test for human contamination. It is recommended by the Consortium that marker 11--1 be removed from the multiplex PCR assay due to the abnormal peak morphology in the amplified products. The removal of this marker will not affect the overall informativeness of the remaining 18 mouse STR markers and their ability to discriminate between the fifty mouse cell lines tested.

Future plans include collaboration between NIST and ATCC to develop an allelic ladder to increase allele coverage and aid in more accurate allele calls. A written consensus standard for mouse cell line authentication would be useful to the community to establish rules and guidelines. Points to be considered for a future consensus standard include: allelic ladder, stutter filter recommendations, DNA quantitation methods, and troubleshooting. The NIST-validated STR profiles from this study have be added to the NCBI BioSample database (<https://www.ncbi.nlm.nih.gov/biosample/?term=mouse+cell+line+STR+profile%5Battribute+name%5D>) with BioProject accession number PRJNA539973. The cell lines listed in the database, having greater than 98% allele consensus among the Consortium laboratory members, have background information included, allele calls for 18 mouse STR markers, and their associated electropherograms.

Finally, it is important to note that concordance in STR profile among the Consortium determines the accuracy to perform and interpret the STR results and does not demonstrate complete authenticity of a particular cell line. However, there is enough confidence that a concordance value greater than 98% provides an accurate STR profile for the identity of mouse cell lines. The STR profiles published on the NCBI BioSample database are validated by the Consortium based on the cell lines provided by ATCC. These STR profiles are the first step in authentication of mouse cell lines.

Materials and methods {#sec015}
=====================

Several activities were performed by NIST in preparation of the interlaboratory study. Some of these activities included:

1.  Preparation of DNA from 50 mouse cell lines and one human cell line

2.  Calculating stutter ratios from diploid mouse DNA samples

3.  Preparation of calibrants

4.  Preparation of primers

5.  Preparation of kit ReagentsProtocols

Preparation of cell line DNA samples {#sec016}
------------------------------------

Fifty-one cell lines (50 mouse, one human) of seed stock material were provided by ATCC (see [Table 9](#pone.0218412.t009){ref-type="table"}) to NIST for the interlaboratory study for mouse STR genotyping. Vials of frozen cell lines were stored in a -150 °C freezer upon receipt.

10.1371/journal.pone.0218412.t009

###### Cell lines used in the interlaboratory study.
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  Code   ATCC\#     Cell Line Designation   Mouse Strain        Tissue Type and/or Disease
  ------ ---------- ----------------------- ------------------- ------------------------------------------------------------------
  M01    CCL-1      NCTC clone 929          C3H/An              Subcutaneous connective tissue
  M02    CCL-1.4    A9                      C3H/An              Subcutaneous connective tissue
  M03    CCL-163    BALB/3T3 clone A31      BALB/c              Embryo
  M04    CCL-219    L1210                   DBA/2               Lymphocytic leukemia
  M05    CCL-223    CMT-93                  C57BL/icrf          Rectal, Polyploid carcinoma
  M06    CCL-92     3T3-Swiss albino        Swiss               Embryo
  M07    CRL-1503   STO                     SIM                 Mouse embryonic fibroblasts
  M08    CRL-1580   P3X63Ag8.653            BALB/c              Plasmacytoma/Myeloma
  M09    CRL-1581   Sp2/0-Ag14              BALB/c              Spleen, Myeloma
  M10    CRL-1636   NMuMG                   NAMRU               Mammary gland
  M11    CRL-1642   LL/2 (LLC1)             C57BL               Lewis Lung carcinoma
  M12    CRL-1658   NIH/3T3                 Swiss               Embryo
  M13    CRL-1696   McCoy (McCoy B)         C3H/An              Synovial fluid in the knee joint
  M14    CRL-1751   WEHI 164                BALB/c              Fibrosarcoma
  M15    CRL-1825   P19                     C3H/He              Teratocarcinoma/Embryonal carcinoma
  M16    CRL-1830   Hepa 1--6               C57L                Liver, Hepatoma
  M17    CRL-1838   M-NFS-60                NFS/N (NFSxDBA/2)   Blood, Myelogenous leukemia
  M18    CRL-1841   HT-2 clone A5E          BALB/c              Spleen
  M19    CRL-2026   Hepa-1c1c7              C57L                Liver, Hepatoma
  M20    CRL-2038   M-1                     Tg(SV40)Bri/7       Normal renal tissue, SV-40 transfected
  M21    CRL-2065   MLTC-1                  C57BL/6             Testis, Leydig cell tumor
  M22    CRL-2113   E.G7-OVA                C57BL/6N            Blood, Lymphoma
  M23    CRL-2116   JC                      BALB/cRos           Mammary adenocarcinoma
  M24    CRL-2123   mIMCD-3                 Tg(SV40)Bri/7       Kidney medullary duct, SV-40 transfected
  M25    CRL-2148   WEHI-13VAR              BALB/c              Fibrosarcoma
  M26    CRL-2278   RAW 264.7 gamma NO(-)   BALB/c              Macrophage, virus transformed
  M27    CRL-2279   MS1 (Mile Sven 1)       C57BL/6             Pancreas/islet of Langerhans, SV-40 transfected
  M28    CRL-2469   EOC 20                  C3H/HeJ             Brain
  M29    CRL-2539   4T1                     BALB/cfC3H          Breast, Mammary tumor (stage IV)
  M30    CRL-2623   W-20-17                 W++                 Bone marrow, Stroma
  M31    CRL-2638   CT26.WT                 BALB/c              Colon carcinoma
  M32    CRL-2639   CT26.CL25               BALB/c              Colon carcinoma
  M33    CRL-2755   EMT6                    BALB/cCrgl          Breast, Mammary carcinoma
  M34    CRL-2947   Renca                   BALB/cCr            Kidney, Renal adenocarcinoma
  M35    CRL-6322   B16-F0                  C57BL/6J            Skin, Melanoma
  M36    CRL-6323   B16-F1                  C57BL/6J            Skin, Melanoma
  M37    TIB-160    YAC-1                   A/Sn                Lymphoma, MLV[\*](#t009fn001){ref-type="table-fn"}-induced
  M38    TIB-192    M1                      SL                  Lymphocyte, Myeloid leukemia
  M39    TIB-197    BCL1 clone 5B1b         BALB/c              Leukemia/Lymphoma
  M40    TIB-208    A20                     BALB/cAnN           B lymphocyte, Reticulum cell sarcoma
  M41    TIB-214    CTLL-2                  C57BL/6             Cytotoxic T lymphocyte
  M42    TIB-224    D10.G4.1                AKR/J               Lymph Node, Helper T lymphocyte
  M43    TIB-239    2E8                     BALB/c.xid          Bone marrow
  M44    TIB-39     EL4                     C57BL/6N            T lymphocyte, Lymphoma
  M45    TIB-49     C1498                   C57BL/6J            Lymphocyte, Acute myeloid leukemia
  M46    TIB-6      J558                    BALB/c              B lymphocyte, Plasmacytoma/myeloma
  M47    TIB-64     P815                    DBA/2               Mast cell, Mastocytoma
  M48    TIB-66     Sarcoma 180             Swiss Webster       Ascites, Sarcoma
  M49    TIB-68     WEHI-3                  BALB/c              Peripheral blood, Leukemia
  M50    TIB-71     RAW 264.7               BALB/c              Ascites, AMLV[\*](#t009fn001){ref-type="table-fn"}-induced tumor
  H1     CRL-1486   HEPM (Human)            Not applicable      Palatal mesenchyme

\*Moloney leukemia virus (MLV); Abelson murine leukemia virus (AMLV)

### DNA isolation {#sec017}

DNA extraction was performed on the washed cell pellets using Quick-DNA Miniprep (Zymo Research, Irvine, CA, USA) following the manufacturer's protocol for Cell Monolayer Samples.

### DNA concentration {#sec018}

DNA concentrations were determined using the Quant-iT Qubit dsDNA BR Assay Kit (Invitrogen, Carlsbad, CA, USA) and fluorescence was measured using the Qubit 3 Fluorometer (Invitrogen). Based on those values, the DNA was diluted to 2 ng/μL in TE (10 mM Tris-HCl (pH 8.0), 0.1 mM EDTA) (Ambion, Foster City, CA, USA) and final DNA concentrations were determined using the Quant-iT Qubit dsDNA HS Assay Kit (Invitrogen) and fluorescence measured using the Qubit 3 Fluorometer (Invitrogen).

### DNA purity {#sec019}

DNA purity was determined by absorbance using the Synergy MX and the Take3 micro-volume plate (BioTek, Winooski, VT, USA) with an optical pathlength of 0.5 mm. A260/A280 ratios were between 1.83 to 1.92 (values greater than or equal to 1.8 are ideal for DNA purity).

Fifty-one cell line DNA samples were blinded and provided a code (mouse cell lines were coded M01 through M50 and the human cell line was coded H1). 20 μL of each DNA sample, concentrations ranging from 2 ng/μL to 2.7 ng/μL, were aliquoted into labeled 0.2 mL 8-strip tubes. Each of the Consortium laboratory members received duplicate DNA samples.

Diploid mouse DNA samples used to calculate stutter ratios {#sec020}
----------------------------------------------------------

Genomic DNA samples from 48 mouse strains obtained from Jackson Laboratories (Bar Harbor, ME, USA), two mouse strains obtained from Zyagen (San Diego, CA), and 15 wild-caught mice (courtesy of Dr. Michael Nachman, University of Arizona, USA) were used in calculating stutter ratios for normal diploid mouse samples to create stutter filter recommendations.

Preparation of calibrants from diploid mouse DNA {#sec021}
------------------------------------------------

Genomic DNA samples from 12 mouse strains obtained from Jackson Laboratories were used to create five calibrant DNA samples (C1 through C5). The DNA calibrant samples were prepared from the following 12 strains of mice: C58/J, CE/J, BTBR T\<+\> tf/J, NZW/LacJ, NOD/ShiLtJ, WSB/EiJ, A/J, KK/HlJ, MA/MyJ, C3H/HeJ, I/LnJ, and NZB/BlNJ. The calibrants were used to assign alleles. Sanger sequencing was performed on each strain at all 19 STR loci to correlate the number of repeating units with fragment length. These highly characterized DNA samples were diluted to approximately 2 ng/μL in TE buffer (10 mM Tris-HCl, pH 8.0, 0.1 mM EDTA) (Ambion) and quantified using Qubit dsDNA HS Assay Kit (Invitrogen) and Qubit 4 Fluorometer (Invitrogen). The various DNA samples were combined in a single tube to prepare each calibrant

-   Calibrant 1 (C1): C58/J, CE/J, BTBR T\<+\> tf/J were combined at a 1:1:1 ratio, each 2 ng/μL

-   Calibrant 2 (C2): NZW/LacJ, NOD/ShiLtJ, WSB/EiJ were combined at a 1:1:1 ratio, each 2 ng/μL

-   Calibrant 3 (C3): A/J, KK/HlJ, MA/MyJ were combined at a 1:1:1 ratio, each 2 ng/μL

-   Calibrant 4 (C4): C3H/HeJ and I/LnJ were combined at a 1:1 ratio, each 2 ng/μL

-   Calibrant 5 (C5): NZB/BlNJ, 2 ng/μL

Calibrants were aliquoted into 0.2 mL 8-strip tubes (20 μL) in triplicate for all Consortium laboratory members. The STR profile for Calibrant 1 is shown in [Table 10](#pone.0218412.t010){ref-type="table"} and an example of the associated electropherogram for Calibrant 1 can be found in [S2 Fig](#pone.0218412.s013){ref-type="supplementary-material"}.

10.1371/journal.pone.0218412.t010

###### STR profile for Calibrant 1 (C1).
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  STR Marker   Alleles
  ------------ ----------------
  18--3        16,19,21
  4--2         16.3,19.3,20.3
  11--1        19.3,20.3
  6--7         12,15,16
  19--2        12,13,14
  1--2         13,15,18
  7--1         26.2,28,29
  1--1         11,14
  3--2         13.1,14
  8--1         14,15,16
  2--1         9
  15--3        20.3,22.3,23.3
  6--4         15.3,18,18.3
  11--2        15,15.3,18
  17--2        15,16
  12--1        15,16,18
  5--5         13,16,17
  X-1          24,25,28
  13--1        16.2,17,18

Preparation of primers to target mouse STR markers {#sec022}
--------------------------------------------------

Primers for 19 mouse STR markers were developed for intraspecies identification of mouse cell lines. The multiplex PCR primers target the following 19 mouse loci: 18--3, 4--2, 11--1, 6--7, 19--2, 1--2, 7--1, 1--1, 3--2, 8--1, 2--1, 15--3, 6--4, 11--2, 17--2, 12--1, 5--5, X-1 and 13--1. The repeat motif for each STR marker was determined by sequencing to correlate fragment length with repeat number. In addition to the mouse STR markers, two well characterized human STR markers D8S1106 and D4S2408, previously described to identify human and African green monkey DNA \[[@pone.0218412.ref022], [@pone.0218412.ref023]\], are also included in the kit to screen for contamination of mouse cell lines with human cells ([Table 11](#pone.0218412.t011){ref-type="table"}). [Table 11](#pone.0218412.t011){ref-type="table"} contains the primer sequences that make up the multiplex PCR assay. Forward primers were labeled with one of the following fluorescent dyes at the 5' end: 6FAM (blue), VIC (green), NED (yellow), or PET (red) (Applied Biosystems). In some cases, an additional guanine base (G) or a ''PIGtail" sequence (`GTTTCTT`) was added to the 5' end of the unlabeled reverse primer to promote complete adenylation and are underlined in the reverse primer \[[@pone.0218412.ref017]\]. The final primer concentrations for the forward and reverse primers in a 20 μL reaction volume were optimized based on DNA concentration and the number of cycles in the PCR program.

10.1371/journal.pone.0218412.t011

###### Mouse multiplex PCR assay.
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  Marker    Species   Chr Loc.   Forward Primer (5\'-3\')           Reverse Primer (5\'-3\')               Final \[Primer\] in 20μL (μM)
  --------- --------- ---------- ---------------------------------- -------------------------------------- -------------------------------
  18--3     mouse     18         `[6FAM]-TCTTTCTCCTTTTGTGTCATGC`    `GTTTCTTGCTAAATAACTAAGCAAGTGAACAGA`    150
  4--2      mouse     4          `[6FAM]-AAGCTTCTCTGGCCATTTGA`      `GTTCATAAACTTCAAGCAATGACA`             200
  11--1     mouse     11         `[6FAM]-CCAGCCAGCCACTCTAGTTA`      `GTTTCTTACAGCTTCAGGACCATGGAA`          150
  6--7      mouse     6          `[6FAM]-AGTCCACCCAGTGCATTCTC`      `GTTTCTTCATGTGGCTGGTATGCTGTT`          200
  19--2     mouse     19         `[6FAM]-AGGCTAGCACTGTTCCTTGT`      `GTTTCTTACTCAGCACCTTCCATCCTG`          200
  1--2      mouse     1          `[VIC]-TCTTTAAAAATCAAACAGGCAAA`    `GTTTCTTGGGGAGGTTGGGGTGTATAA`          225
  7--1      mouse     7          `[VIC]-ACACCAGTTGGGGACTAGGA`       `GTTTCTTAACTGGTGCTGGGTCTGAAC`          200
  1--1      mouse     1          `[VIC]-CCCTTCACTCCTTCATTCCA`       `GTTTCTTTGAGCCTAAGGACCTGGACA`          150
  3--2      mouse     3          `[VIC]-TGAGCTACCATGTGGGTACA`       `GTTTCTTCACACACACACACAAAGATGGA`        200
  8--1      mouse     8          `[VIC]-AGTAATATCCTGGTCCTGGCC`      `GTTTCTTGAGCTCACTATGTAGCTATTGGA`       200
  2--1      mouse     2          `[NED]-ACAACTTCAAACTTTGCTGGAA`     `GTTTCTTTCCTGCTTAGCTTGTCATTTCC`        125
  15--3     mouse     15         `[NED]-TCTGGGCGTGTCTGTCATAA`       `GTTTCTTAGGCTATCTAAACTTGACATGCT`       100
  6--4      mouse     6          `[NED]-TTTGCAACAGCTCAGTTTCC`       `GTTTCTTAATCGCTGGCAGATCTTAGG`          200
  11--2     mouse     11         `[NED]-AAGGCAGGGGAATTCACAGT`       `GTTTCTTTCTCACCATTGCAGTCCTGA`          200
  17--2     mouse     17         `[PET]-CTCTTCTCCATCCGTCCATC`       `GTTTCTTATGGCTCTTGCCACAAATCT`          200
  12--1     mouse     12         `[PET]-TTTCAAAATTGTCATTGAACACA`    `GTTTCTTTGGTCCTTCAGTATCATCCTTG`        200
  5--5      mouse     5          `[PET]-CGTTTTACCTGGCTGACACA`       `GTTTCTTTGGTTTAAAACTCAATACCAAACAA`     250
  X-1       mouse     X          `[PET]-AACAAAAATGTCCCTCAATGC`      `GTTTCTTAAGGTATATATCAAGATGGCATTATCA`   275
  13--1     mouse     13         `[PET]-AACTCCCACTGCTTCTTGGT`       `GTTTCTTGCCAAAGTAAACCCTTCTCCC`         250
  D8S1106   human     8          `[VIC]-TCTGCTGATTGTGCCCATTG`       `GTTTCTTATTGGCTGGTTAGTGACACA`          200
  D4S2408   human     4          `[NED]-TCATTTCCATAGGGTAAGTGAAAA`   `GTTTCTTGCCATGGGGATAAAATCAGA`          250

Characterization of calibrants {#sec023}
------------------------------

### PCR amplification for sequencing {#sec024}

Sequencing reactions for calibrant samples (C1 through C5) were prepared using the following 20 μL reaction mixture: 4--5 ng of template DNA, 1X GeneAmp PCR Gold buffer (Thermo Fisher), 1.5 mM MgCl~2~ (Thermo Fisher), 1 U AmpliTaq Gold Polymerase (Thermo Fisher), 0.15 μM unlabeled forward and reverse primers (see [S6 Table](#pone.0218412.s010){ref-type="supplementary-material"}), 0.16 mg/mL non-acetylated BSA (Invitrogen), 200 μM dNTPs (Invitrogen), and PCR grade water. The SeqAmp program was run on the Veriti (Applied Biosystems) with the following parameters: denaturation for 10 min at 95 °C, amplification for 35 cycles of 1 min at 94 °C, 1 min at 55--60 °C (annealing temperature specific to individual primers), and 1 min at 72 °C, extension for 45 min at 60 °C, followed by a hold at 25 °C.

### Sequencing STR markers in calibrants {#sec025}

To determine the number of repeat units for each fragment length (allele) for the 19 mouse STR markers, each calibrant was subjected to Sanger sequencing. Each calibrant (C1 through C5) DNA sample was amplified with primers targeting all 19 mouse STR markers in single-plex. Amplicons were treated with 2 μL of ExoSap-IT (Applied Biosystems) per 5 μL of PCR product to remove unincorporated primers and deoxyribonucleotide triphosphates (dNTPs) by incubating samples for 90 min at 37 °C followed by 20 min at 80 °C to inactivate the enzymes. Samples were then sent to Eurofins MWG Operon (Louisville, KY, USA) for Sanger sequencing. Resulting sequence profiles were received after data analysis was performed by Eurofins MWG Operon. Lasergene 15.2 (DNA Star, Madison, Wisconsin, USA) alignment software, SeqMan Pro, was used to determine repeats for each allele at every STR marker.

### PCR amplification for genotyping calibrants {#sec026}

PCR amplification of calibrant samples (C1 through C5) and optimization of CE parameters was completed by the Consortium laboratory members prior to running the full panel of mouse cell line DNA (M01 through M50). Detailed methods are described in [S1 File](#pone.0218412.s001){ref-type="supplementary-material"} but will be explained briefly here. Each PCR reaction contained 12.5 μL of Qiagen Type-It Microsatellite PCR Mix (MM), 2.5 μL of primers (P21), 9 μL of PCR grade water, and 1 μL of DNA template (approximately 2ng/μL). To improve signal in samples, many labs had to increase the input DNA volume to 2 μL in the reaction. PCR reactions were placed on a thermal cycler with the following parameters: denaturation at 95 °C for 5 min, 29 cycles of amplification step (95 °C for 30 sec, 59 °C for 90 sec, 72 °C for 30 sec), soak at 60 °C for 90 min, and a hold at 25 °C. After optimization of the assay was completed using calibrant DNA, PCR was performed on the full panel of mouse cell line DNA. PCR Master Mix for the 50 mouse DNA samples (M01 through M50), five Calibrants (C1 through C5), one human DNA control (H1), and one negative control (water) was prepared using the same conditions as described for the calibrants.

### Separation and analysis of PCR products {#sec027}

PCR amplicons were prepared for capillary electrophoresis by adding 9.5 μL of Hi-Di Formamide (Applied Biosystems) and 0.5 μL of GeneScan 600 v2 LIZ internal size standard (Applied Biosystems) to 1 μL of PCR product to each well in a 96-well plate. The 96-well plate was briefly centrifuged at 2000 x g for one minute. The plate was loaded onto the Applied Biosystems 3500xl Genetic Analyzer (or equivalent) (use a STR cassette base if needed). A five-dye DS-33 Matrix Standard Kit (Applied Biosystems) was previously established under the G5 filter with the following dyes: 6FAM, VIC, NED, PET, and LIZ (as per manufacturer's instruction). Conditions for running an Applied Biosystems 3500xl 36cm array using POP-4 polymer was provided to the Consortium laboratory members and specific adjustments were made individually based on the instrument, array, and polymer being used. The conditions for capillary electrophoresis (CE) using a 3500xl, 36cm array, POP-4 were as follows: oven temp (60 °C), run time (1500 sec), run voltage (15kV), pre-run time (180 sec), pre-run voltage (15 kV), injection time (15 sec), injection voltage (1.2 kV), and data delay (1 sec). Consortium laboratory members were provided a specific set of files for their version of software (which may include bins and panels, analysis method, plot settings, size settings, and table settings).

Preparation of mouse STR validation kit and protocol distribution {#sec028}
-----------------------------------------------------------------

The kits were prepared at NIST. Each kit provided to a Consortium laboratory member contained the following:

-   DNA from 50 mouse cell lines (two tubes of each mouse cell line DNA; each tube containing 20 μL of 2 ng/μL of DNA). Each mouse cell line DNA was numerically coded for blind experimentation to avoid experimental bias (M01 through M50)

-   Five Calibrant DNA samples labeled C1 through C5 (three tubes of each calibrant; each tube containing 20 μL of 2 ng/μL DNA)

-   One human DNA control sample labeled H1 (two tubes of human DNA each containing 20μL of 2 ng/μL DNA)

-   PCR Master Mix (Qiagen Type-It Microsatellite PCR Kit, Qiagen, Hilden, Germany) labeled MM. (Three tubes of Master Mix; each containing 0.850 mL)

-   Primers for 19 mouse STR markers and two human STR markers labeled P21 (each tube containing 400 μL). Primer mix was tested for signal intensity and presence of accurate allele calls using the calibrant DNA samples and the multiplex PCR assay prior to distribution.

Kits were distributed on dry ice to each Consortium laboratory member by ATCC under appropriate DOT shipping regulations.

Instructions to consortium laboratory members {#sec029}
---------------------------------------------

The following instructions were given to the Consortium laboratory members. Upon receipt, kit should be stored at -20 °C. Once kit components were thawed for use, subsequent storage of kit components were as follows: Qiagen Type-It Microsatellite PCR Master Mix (MM) should be stored at -20 °C and all DNA samples (M01-M50), Calibrants (C1-C5), and Human Control (H1), and should be stored at 4 °C. Mouse Multiplex Primers (P21) are light sensitive and should be stored in the dark at 4 °C.

In addition to receiving the test kit provided by NIST/ATCC, each Consortium laboratory member was responsible for purchasing the internal size standard GeneScan LIZ 600 v2 (Applied Biosystems) and DS-33 G5 dye matrix (Applied Biosystems) to allow for proper sizing of PCR fragments and to calibrate the CE instrument for the fluorescent dyes used in the assay. The following files were distributed to each consortium member describing PCR sample preparation, thermal cycling conditions, CE conditions, software analysis and settings, and interpretation of data (see supplemental materials):

-   Protocol 1: STR profiling of mouse cell lines ([S1 File](#pone.0218412.s001){ref-type="supplementary-material"})

-   Protocol 2: Data Analysis: GeneMapper ID-X Software; GeneMapper IDv3.2.1, GeneMapper v4.0, v4.1, v5.0 Software ([S2 File](#pone.0218412.s002){ref-type="supplementary-material"})

-   Protocol 3: Data Analysis: SoftGenetics GeneMarker Software Version 1.85; Version 2.6.3 or Version 2.7.6 ([S3 File](#pone.0218412.s003){ref-type="supplementary-material"})

-   STR Profiles for Five Calibrant DNA Samples ([S4 Table](#pone.0218412.s008){ref-type="supplementary-material"})

-   Extrapolation of alleles for bin set ([S5 Table](#pone.0218412.s009){ref-type="supplementary-material"})

-   Electropherograms for each of the five calibrants ([S2](#pone.0218412.s013){ref-type="supplementary-material"}--[S6](#pone.0218412.s017){ref-type="supplementary-material"} Figs)

-   Bins and panels, analysis methods, table settings, plot settings, size settings ([S4 File](#pone.0218412.s004){ref-type="supplementary-material"})

Using the protocols, tables and bins/panels provided, each lab was asked to adjust the bins and panels in their respective software platform using the calibrant samples prior to running the 50 mouse DNA samples. Once the instruments and protocols were optimized for the calibrant samples, all samples were genotyped and analyzed. A successful run was determined by the presence of all alleles in the calibrant samples detected above threshold levels, amplification of the human control (H1) at the human STR markers, and no amplification of alleles in the negative control.

Stutter filter calculations {#sec030}
---------------------------

Stutter ratios were calculated by dividing the height of the stutter peak by the height of the allelic peak \[[@pone.0218412.ref024]\]. Only peak heights above 100 RFUs were used in stutter ratio calculations. The general stutter guidelines were borrowed from human cell line authentication \[[@pone.0218412.ref007]\] and are as follows: 1) A peak in the -4 stutter position with a stutter ratio greater than 20% would be called an allele, and 2) A peak in the +4 stutter position with a stutter ratio above 10% would be called an allele.

To assess whether stutter ratios were affected by measurement platform, a Friedman test \[[@pone.0218412.ref015]\] was conducted using average stutter ratio (normalized to account for variation due to allele length) from each marker for each instrument as input. For each marker, the four considered instruments are ranked in order of average stutter ratio. A Friedman test looks for patterns in these rankings to assess whether any instrument tends to produce higher or lower stutter ratios than the other instruments. A Friedman test does not make any assumptions about the specific distributional form of the stutter ratios, and accounts for differences in average stutter ratios across markers.

Stutter ratios were also calculated for each allele present in the collection of genomic DNA from Jackson Laboratories, Zyagen, and wild-caught mouse samples from Michael Nachman's lab at the University of Arizona. Allele-specific and marker-specific stutter ratios were determined for all alleles present in the samples tested. Allele-specific stutter filters were computed as the average of stutter ratios reported for the allele across samples plus three standard deviations. Marker-specific stutter filters were computed as the average of all reported stutter ratios across alleles within a marker plus three standard deviations \[[@pone.0218412.ref016]\]. Incorporating stutter filters in fragment analysis software will aid in future allele calling and flag samples with peak height imbalances that may need further review.

Concordance {#sec031}
-----------

A cell line was considered concordant if all Consortium laboratory members obtained the same allele calls at all 19 loci. For each allele call within each cell line, an agreement proportion was computed as the fraction of the other 11 Consortium laboratory members that also called that allele. For example, suppose for a given marker in a given cell line that 12 Consortium laboratory members called allele 17 and 11 Consortium laboratory members called allele 19 and no other allele calls were made for this marker. The allele agreement for each of the allele 17 calls would be 11/11 = 1, and the allele agreement for each of the allele 19 calls would be 10/11 = 0.909. Allele agreement for each marker was determined by calculating the average agreement proportion across all allele calls for that marker. The agreement score for the marker in the example above would be $\frac{12*\left( \frac{11}{11} \right) + 11*\left( \frac{10}{11} \right)}{23} = 0.957$, where 23 appears in the denominator because that is the total number of allele calls made for this marker across all groups. Allele agreement was also assessed at the cell line level by computing the average agreement proportion across all alleles and markers. As the term, "agreement proportion" implies, this measure of correspondence conveys the average proportion of the other labs that would agree with a given allele call.

Supporting information {#sec032}
======================

###### Protocol 1: STR profiling of mouse cell lines.

Detailed instructions were provided to the Consortium laboratory members regarding sample handling, PCR conditions, and preparing samples for capillary electrophoresis.

(PDF)

###### 

Click here for additional data file.

###### Protocol 2: Data analysis using GeneMapper software.

Data Analysis instructions for GeneMapper ID-X Software; GeneMapper IDv3.2.1, GeneMapper v4.0, v4.1, v5.0 Software platforms.

(PDF)

###### 

Click here for additional data file.

###### Protocol 3: Data analysis using GeneMarker software.

Data Analysis instructions for SoftGenetics GeneMarker Software Version 1.85; Version 2.6.3 or Version 2.7.6 platforms.

(PDF)

###### 

Click here for additional data file.

###### Bins, panels, analysis method, plot setting, size setting, and table setting for each software platform used in the interlaboratory study (compressed file).

(ZIP)

###### 

Click here for additional data file.

###### Allele-specific stutter ratios.

Average allele-specific stutter ratios were determined using normal diploid mouse strain DNA samples. The upper stutter limit was calculated as the mean plus 3 standard deviations, where the standard deviation corresponds to the collection of stutter ratios observed for that specific allele in that specific marker.

(XLSX)

###### 

Click here for additional data file.

###### Genotype uniqueness of DNA samples using 18 out of 19 STR markers.

This table reports each sample's nearest neighbor (where distance between samples is assessed as the total number of alleles across markers that are present in one sample but not the other).

(XLSX)

###### 

Click here for additional data file.

###### Pairwise comparison using Master's algorithm.

A pairwise comparison of the mouse cell lines and diploid mouse strains was performed using Master's algorithm.

(XLSX)

###### 

Click here for additional data file.

###### STR profiles for the five calibrant DNA samples.

Alleles present for each calibrant at 19 mouse STR markers.

(XLSX)

###### 

Click here for additional data file.

###### Extrapolation of alleles for bin set.

The table shows possible alleles present for each mouse STR marker. Alleles highlighted in yellow are represented in the calibrant samples provided. Extrapolate fragment lengths of calibrants +4 bp or -4 bp to unrepresented alleles to aid in allele determination of test samples.

(XLSX)

###### 

Click here for additional data file.

###### Sequencing primers used to characterize the calibrant DNA samples.

Primers were used to sequence STR regions to determine actual number of repeats (alleles) and correlate with fragment length obtained using capillary electrophoresis.

(XLSX)

###### 

Click here for additional data file.

###### STR profiles for validated mouse cell lines at 18 STR markers.

Consensus allele calls (greater than 98%) determined by the Consortium laboratory members.

(XLSX)

###### 

Click here for additional data file.

###### Electropherogram of human cell line control (HEPM).

Amplification of human alleles present at D8S1106 and D4S2408 in the HEPM cell line using the multiplex PCR assay targeting 19 mouse STR markers and two human STR markers.

(TIF)

###### 

Click here for additional data file.

###### Electropherogram of Calibrant 1.

STR profile shown for Calibrant 1, a mixed diploid DNA sample from C58/J, CE/J, and BTBR T\<+\> tf/J mice, at 19 mouse STR markers.

(TIF)

###### 

Click here for additional data file.

###### Electropherogram of Calibrant 2.

STR profile shown for Calibrant 2, a mixed diploid DNA sample from NZW/LacJ, NOD/ShiLtJ, and WSB/EiJ mice, at 19 mouse STR markers.

(TIF)

###### 

Click here for additional data file.

###### Electropherogram of Calibrant 3.

STR profile shown for Calibrant 3, a mixed diploid DNA sample from A/J, KK/HlJ, and MA/MyJ mice, at 19 mouse STR markers.

(TIF)

###### 

Click here for additional data file.

###### Electropherogram of Calibrant 4.

STR profile shown for Calibrant 4, a mixed diploid DNA sample from C3H/HeJ and I/LnJ mice, at 19 mouse STR markers.

(TIF)

###### 

Click here for additional data file.

###### Electropherogram of Calibrant 5.

STR profile shown for Calibrant 5, a diploid DNA sample from an NZB/BlNJ mouse, at 19 mouse STR markers.

(TIF)

###### 

Click here for additional data file.

###### Electropherogram for the A20 cell line showing balanced peak height.

A20, a sarcoma cell line, is an example of a cell line that has balanced peak height at STR markers 18--3, 6--7, 1--2, and 1--1.

(TIF)

###### 

Click here for additional data file.

###### Electropherogram for CT26.CL25 cell line showing peak height imbalance.

A colon carcinoma cell line, CT26.CL25, has several instances of peak height imbalance shown at STR markers 1--2, 1--1, 2--1, and 6--4.

(TIF)

###### 

Click here for additional data file.
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Disclaimer {#sec033}
==========
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